These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 14039037)

  • 1. [Experiences with a new purified depot insulin (Depot Insulin G 25 "Hoechst")].
    SCHNEEWEISS J
    Med Welt; 1962 May; 18():1052-3. PubMed ID: 14039037
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st clinical experiences with a new depot insulin: human globin insulin].
    MARIGO S; MELANI F
    Praxis; 1962 May; 51():490-3. PubMed ID: 14469824
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of saturation of fat depots in the pathogenesis of insulin resistance.
    Cherian MA; Santoro TJ
    Med Hypotheses; 2006; 66(4):763-8. PubMed ID: 16360289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical observations on a new depot insulin].
    CUGUDDA E; GRAGNOLI G; GIOVANNELLI G
    Ther Umsch; 1963 Jan; 20():21-8. PubMed ID: 14024182
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations on a new depot-insulin].
    MARIGO S; BENAZZO L
    Dtsch Med J; 1958 Sep; 9(9):473-5. PubMed ID: 13609412
    [No Abstract]   [Full Text] [Related]  

  • 7. A problem of insulin dosage.
    FORDHAM CC
    N C Med J; 1961 Jun; 22():259-60. PubMed ID: 13700742
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experineces with insulin-zinc suspensions in the tretment of diabetes].
    SAUER H
    Med Welt; 1961 Feb; 6():287-90. PubMed ID: 13746764
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experiences with di-insulin.
    VARTIAINEN I
    Ann Med Intern Fenn; 1947; 36(3):721-8. PubMed ID: 18914414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of chronic focal infections in the appearance of insulin resistance].
    DZIENISZEWSKI J
    Pol Tyg Lek; 1960 Oct; 15():1579-81. PubMed ID: 13725446
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical value of insulin Novo Rapitard and Actrapid and its objective measurement according to the M-value method (Schlicht-krull)].
    STRATMANN FW
    Med Welt; 1962 Jan; 4():194-8. PubMed ID: 14037787
    [No Abstract]   [Full Text] [Related]  

  • 12. [Considerations on utilization of certain depot and mixture of insulin].
    FOIT R; ZIKMUND E; SIEBEROVA R; PADR Z
    Cas Lek Cesk; 1956 Dec; 95(51):1389-94. PubMed ID: 13404627
    [No Abstract]   [Full Text] [Related]  

  • 13. [Depot forms of insulin].
    PADR Z
    Cesk Farm; 1955 Jun; 4(5):255-8. PubMed ID: 14390589
    [No Abstract]   [Full Text] [Related]  

  • 14. The subjective experiences of people who regularly receive depot neuroleptic medication in the community.
    Phillips L; McCann E
    J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience with depot-insulin; 72 case reports].
    CAINO HV; CABARROU A; BIANCHI NO; PINTADO O
    Sem Med; 1957 Jul; 111(4):172-4. PubMed ID: 13486160
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of insulin, Rules for insulin medication].
    BEGUIRISTAIN MA; GARDA EA
    Sem Med; 1961 Apr; 118():734-40. PubMed ID: 13688677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin resistance].
    LARCAN A; HURIET C; VERT P
    Presse Med (1893); 1960 Oct; 68():1659-61. PubMed ID: 13759086
    [No Abstract]   [Full Text] [Related]  

  • 18. PPAR-gamma2 expression in response to cafeteria diet: gender- and depot-specific effects.
    Rodríguez E; Ribot J; Rodríguez AM; Palou A
    Obes Res; 2004 Sep; 12(9):1455-63. PubMed ID: 15483210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue leptin and plasma insulin are associated with lipoprotein lipase activity in severely obese patients.
    Ramis JM; Bibiloni B; Moreiro J; García-Sanz JM; Salinas R; Proenza AM; Lladó I
    J Nutr Biochem; 2005 May; 16(5):279-85. PubMed ID: 15866227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with a new depot sedative proscalun].
    SCHEERER A
    Med Monatsschr; 1957 Aug; 11(8):520-3. PubMed ID: 13464422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.